Table 1 Rating the levels of evidence (LoE) for EFSUMB CPGs based on the Oxford Center of Evidence-Based Medicine (OCEBM) system, version 2 (2011; modified from 36 ).
Clinical question | LoE 1* | LoE 2* | LoE 3* | LoE 4* | LoE 5* |
---|---|---|---|---|---|
How common is the problem? | Local and current random sample surveys (or censuses) | Systematic review of surveys that allow matching to local circumstances** | Local non-random sample** | Case series** | Not applicable |
Is this diagnostic test accurate? (Diagnosis) | Systematic review of cross-sectional studies with consistently applied reference standard and blinding | Individual cross-sectional study with consistently applied reference standard and blinding | Non-consecutive studies, or studies without consistently applied reference standards** | Case control studies or poor or non-independent reference standard** | Mechanism-based reasoning |
What will happen if we do not add a therapy? (Prognosis) | Systematic review of inception cohort studies | Inception cohort studies | Cohort study or control arm of randomized trial** | Case series or case control studies or poor quality prognostic cohort study** | Not applicable |
Does this intervention help? (Treatment Benefits) | Systematic review of randomized trials or n -of-1 trials | Randomized trial or observational study with dramatic effect | Non-randomized controlled cohort/follow-up study** | Case series, case control studies, or historically controlled studies** | Mechanism-based reasoning |
What are the common harms? (Treatment Harms) | Systematic review of randomized trials, systematic review of nested case control studies, n -of-1 trial with the patient you are raising the question about, or observational study with dramatic effect | Individual randomized trial or (exceptionally) observational study with dramatic effect | Non-randomized controlled cohort/follow-up study (post-marketing surveillance) provided there are sufficient numbers to rule out a common harm (for long-term harms the duration of follow-up must be sufficient)** | Case series, case control studies, or historically controlled studies** | Mechanism-based reasoning |
What are the rare harms? (Treatment Harms) | Systematic review of randomized trials or n -of-1 trial | Randomized trial or (exceptionally) observational study with dramatic effect | |||
Is this (early detection) test worthwhile? (Screening) | Systematic review of randomized trials | Randomized trial | Non-randomized controlled cohort/follow-up study** | Case series, case control studies, or historically controlled studies** | Mechanism-based reasoning |
* LoE may be graded down on the basis of study quality, imprecision, indirectness (study PICO does not match questions PICO), because of inconsistency between studies, or because the absolute effect size is very small; LoE may be graded up if there is a large or very large effect size. PICO : P atient, P opulation, or P roblem; I ntervention, Prognostic factor, or Exposure; C omparison of intervention (if appropriate); O utcome you would like to measure or achieve)
** A systematic review is generally better than an individual study.